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Background:  Optimal management for coarctation of the aorta and ventricular sep-
tal defect remains controversial. The current study was undertaken to determine
outcome, including recoarctation after 2-stage repair, at our institution.
Methods:  Between 1984 and 1998, 79 patients younger than 3 months with coarc-
tation and ventricular septal defect underwent 2-stage repair at our institution. The
first-stage operation consisted of subclavian flap angioplasty and pulmonary band-
ing. The median age at the time of first operation was 28 days (range, 4-90 days),
and median weight was 3.2 kg (range, 1.2-5.1 kg). Hypoplastic aortic arch was pre-
sent in 27 patients, and coexisting anomalies were present in 13 patients. After a
mean interval of 10.4 ± 9.6 months, they underwent a second-stage repair, with clo-
sure of the ventricular septal defect and pulmonary debanding.
Results:  There were 2 hospital deaths and 4 late deaths. Mean follow-up was 9.2 ±
4.9 years (range, 2.0-18.3 years), and actuarial survival was 92.3% at 10 years (95%
confidence interval, 86.6%-98.3%). Age at first operation, body weight, hypoplas-
tic arch, and coexisting anomalies had no significant influence on overall mortality.
Freedom from recoarctation rate was 90.4% at 10 years (95% confidence interval,
83.7%-97.2%).
Conclusion:  To diminish mortality and the recoarctation rate and also to decrease
the possibility of complications related to circulatory arrest and allogeneic blood
transfusion, 2-stage repair is still an effective technique for coarctation of the aorta
associated with ventricular septal defect.
The optimal management for patients with coarctation of the aorta andventricular septal defect (VSD) remains controversial. The tradition-al 2-stage operation consists of the repair of coarctation with or with-out pulmonary banding through a left thoracotomy and the closureof VSD as a secondary procedure. On the other hand, both coarcta-tion and VSD are repaired at the same time in a single-stage repair.
According to a multi-institutional study in 1994,1 single-stage repair had the lowest
survival, whereas 2-stage repair concomitant with pulmonary artery banding (PAB)
had the highest survival. However, recent studies2,3 have reported good results for a
primary total correction procedure through a midline sternotomy. With 2 surgical
options now available, a major concern is which procedure has the relative benefit,
the single-stage versus the 2-stage repair for coarctation and VSD. This study was
undertaken to determine the outcome, including recoarctation, after so-called tradi-
tional 2-stage repair at our institution.
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Methods
Between 1984 and 1998, 79 patients younger than 3 months who
had coarctation of the aorta and VSD were operated on at the Heart
Institute of Japan (Tokyo Women’s Medical University, Japan).
Patients with transposition of the great arteries, double-outlet right
ventricle, univentricular heart, atrioventricular septal defect, tri-
cuspid atresia, and Ebstein anomaly were excluded from the study.
Patients with interrupted aortic arch were also excluded. The med-
ical records of all these infants were retrospectively reviewed. The
diagnosis of coarctation and VSD, the location of VSD, and the
presence of any coexisting anomalies were determined by echocar-
diography, cardiac catheterization, and operative records. In the
latter part of this period, cardiac catheterization was performed
only when the echocardiographic diagnosis was not conclusive.
Patients
There were 52 (66%) boys and 27 (44%) girls among 79 patients
with coarctation and VSD under 3 months of age. The median age
at the time of operation was 28 days (range, 4-90 days; mean, 37
days), and median weight at the time of operation was 3.2 kg
(range, 1.2-5.1 kg; mean, 3.3 kg). Six patients had ductal shock
and the other 73 patients had congestive heart failure as the pri-
mary indication for operation. Alprostadil (prostaglandin) infu-
sion before the operation was used in 58 (73%) patients.
Hypoplastic arches, defined as narrowest arch diameter of 4 mm
or less,4 were observed in 27 (34%) patients. The location of the
VSD was perimembranous in 47 (59%) patients, subpulmonary in
28 (35%) patients, and muscular in 4 (5.1%) patients. All 4
patients with a muscular VSD had other perimembranous VSDs
(multiple VSDs). Coexisting anomalies were subaortic stenosis in
5 (6.3%) patients, aortic valve stenosis in 4 (5.1%) patients, bicus-
pid aortic valve in 3 (3.8%) patients, and aortic valve regurgitation
in 1 (1.3%) patient.
Surgical Procedures
Our consistent surgical policy for coarctation and VSD has been a 2-
stage repair: coarctation repair by means of subclavian flap angio-
plasty (SFA)5 concomitant with PAB6 as a first-stage procedure and
closure of VSD associated with debanding as a second-stage proce-
dure.
All patients underwent SFA and PAB through a left lateral thora-
cotomy. After heparinization, the left subclavian artery was well
mobilized by dividing all branches, and the ductus arteriosus was li-
gated. The subclavian artery was opened downward into the descend-
ing aorta well beyond the coarctation segment, and the aorta was
enlarged with the subclavian flap with 7-0 Prolene sutures before or
7-0 PDS running sutures (Ethicon, Inc, Somerville, NJ) after July
1987. The pericardium was then incised, and the pulmonary artery
was isolated with a 3-mm wide Teflon tape at the level of bifurcation.
The pulmonary artery was usually banded down to a circumference
of 19 mm plus the patient’s body weight in kilograms. The band was
secured to the adventitia of the pulmonary artery at several portions
to prevent migration and distortion of the pulmonary artery.
Hypoplastic aortic arches were left undisturbed on the basis of our
belief that adequate aortic forward flow is a major factor in the arch
development in this disease. One patient required a second PAB
because he could not be weaned from the ventilator.
After a mean interval of 10.4 ± 9.6 months (range, 9 days-29
months), a second-stage operation was performed through a medi-
an sternotomy, and bicaval cannulation with hypothermic car-
diopulmonary bypass was performed. After total bypass was estab-
lished, the main pulmonary artery was transected at the band site,
TABLE 1. Multivariate analyses between preoperative factors and mortality or recoarctation
Mortality Recoarctation
Factor HR 95% CI P value HR 95% CI P value
Age (d) 0.98 0.96-1.03 .707 0.99 0.97-1.03 .911
Body weight (kg) 0.41 0.13-1.33 .137 0.49 0.18-1.39 .184
Hypoplastic arch (yes vs no) 1.99 0.31-12.6 .466 2.62 0.35-19.7 .349
Coexisting anomalies (yes vs no) 2.25 0.20-25.0 .510 2.01 0.18-22.8 .571
HR, Hazard ratio.
TABLE 2. A summary table of the pros and cons of a single-stage versus 2-stage repair
Single-stage repair Two-stage repair
Survival Worse or equivalent Better or equivalent
Freedom from recoarctation Worse or equivalent (or unknown*) Better or equivalent (or unknown*)
Deep hypothermic circulatory arrest Usually used in many centers Usually not used
Allogeneic blood transfusion Unavoidable Possibly avoidable
Second operation Unnecessary Always necessary (with PAB)
Left subclavian artery Preserved Sacrificed
*Documentation is not definite because different operative techniques of coarctation repair (eg, SFA, extended aortic arch anastomosis, and resection
with end-to-end anastomosis) were performed at the time of 2-stage repair.
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tion. The second patient (18 days of age) died 26 days after the
operation because of heart failure caused by hypertrophic car-
diomyopathy, which was diagnosed by means of echocardio-
graphy that revealed concentric hypertrophy of the left ventri-
cle. There were 4 late deaths (mean, 5.2%; 95% CI,
0.2%-10.1%). Cause of death was low output syndrome 7
hours after the second operation in one patient who had a con-
comitant infundibular resection. The second patient had SFA
and PAB at 12 days of age and peritoneal dialysis at 23 days
of age caused by idiopathic hyperbilirubinemia and underwent
a second-stage operation 26 days after the first operation. He
was unable to be weaned from the ventilator, showed pul-
monary infection and sepsis, and died 34 days after the second
operation. The third patient died of left ventricular failure that
was unresponsive to pharmacologic treatment 9 months after
the second-stage operation. The final patient died of rapidly
progressive congestive heart failure at 32 months after the sec-
ond-stage operation. Mean follow-up in all 73 late survivors
was 9.2 ± 4.9 years (range, 2.0-18.3 years), and the actuarial
survival was 92.3% at 10 years (95% CI, 86.6%-98.3%;
Figure 1). In multivariate analysis, age at the first operation,
body weight at the first operation, the presence of hypoplastic
arch, and coexisting anomalies had no significant influence on
overall mortality (P = .707, P = .137, P = .466, and P = .510,
respectively; Table 1).
Recoarctation
Recoarctation was considered present if the resting systolic
blood pressure gradient across the arch was 20 mm Hg or
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and pulmonary debanding was performed by excising the banded
segment of the main pulmonary artery. The VSD was closed with
a Dacron patch under cardiac arrest induced with crystalloid car-
dioplegia. In one patient plication of the right coronary cusp for
aortic insufficiency was performed during the same operation.
Pulmonary artery continuity was restored by means of an end-to-
end direct anastomosis. The mean duration of cardiopulmonary
bypass was 99 ± 30 minutes, and the mean duration of aortic cross-
clamping was 39 ± 28 minutes.
All patients were followed up at our outpatient unit, and follow-
up was complete and up to date in all patients.
Statistical Analysis
Data computations were performed with the StatView 5.0 (SAS
Institute Inc, Cary, NC) statistical program. Proportion values are
expressed as mean values with 95% confidence intervals (CI).
Continuous data are presented as means ± standard deviation (SD).
Time-related events were examined by Kaplan-Meier actuarial
methods. Preoperative factors associated with the overall mortali-
ty rate or the recoarctation rate were assessed by multivariate
analysis with a Cox proportional hazards regression model. For
analyses of both survival and freedom from recoarctation, the time
of the initial operation was taken as time zero.
Results
Survival
There were 2 hospital deaths (mean, 2.5%; 95% CI, 0.01%-
6.0%). All hospital mortalities were related to the initial oper-
ation performed to repair the coarctation. One patient (15 days
of age), who preoperatively had necrotizing enterocolitis
caused by ductal shock, died of sepsis 5 days after the opera-
Figure 1. Actuarial survival curve after first-stage repair in our
institution. The 95% CIs are provided around the curve, and the
numbers of patients are shown in parentheses.
Figure 2. Actuarial freedom from recoarctation rate after first-
stage repair. The 95% CIs and the numbers of patients (in paren-
theses) are also shown.
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greater, as determined by means of ankle-arm pressures.
Seven patients had recoarctation, and the actuarial freedom
from recoarctation rate was 90.4% at 10 years (95% CI,
83.7%-97.2%; Figure 2). These 7 patients who had recoarcta-
tion underwent balloon dilatation successfully, and no patients
required reoperation. Age, body weight, presence of hypoplas-
tic arch, and coexisting anomalies were not predictors of
recoarctation after 2-stage repair (P = .911, P = .184, P = .349,
and P = .571, respectively) in a multivariate analysis (Table 1).
Discussion
Single-stage repair has 3 potential disadvantages when com-
pared with a 2-stage repair: (1) There is a high mortality
rate, recoarctation rate, or both; (2) deep hypothermic circu-
latory arrest is necessary; and (3) allogeneic blood transfu-
sion is required (Table 2).
A multi-institutional study in 19941 showed that single-
stage repair was associated with the lowest non–risk-adjusted
survival and that survival at 2 years was greatest in patients
who underwent repair of coarctation in conjunction with
PAB. Brouwer and colleagues7 reported that hospital mortal-
ity was 4.7% in the multistage group and 18.8% for the sin-
gle-stage group, although this difference did not reach statis-
tical significance. The actuarial survival at 10 years after the
2-stage operation was reported to be 96%, 94%, 92.6%, and
91% (Table 3).1-3,7-12 These values are similar to our results.
On the other hand, the survival after single-stage repair was
reported to be 80.0% at 2 years, 81.2% at 5 years, 91.0% at
1 year, and 96.0% at 3 years (Table 3).
The actuarial freedom from recoarctation rate (where
recoarctation is defined as a resting peak pressure gradient
of >20 mm Hg across the arch) at 5 years was 91.3% in the
2-stage group versus 60% in the single-stage group.7 Our
results, with a 90.4% freedom from recoarctation rate at 10
years after 2-stage repair, compare favorably with this fig-
ure. Freedom from recoarctation was 75% in another study,
even at 2 years after single-stage repair.3 These lower rates
of freedom from recoarctation compared with 2-stage repair
suggest that, through a sternotomy, ductal tissue was inade-
quately removed to avoid the left bronchial compression13
by the reconstructed aortic arch. This might result in fre-
quent stenosis in the repair area.
Regarding which procedure has better results, SFA or end-
to-end anastomosis, many surgeons may prefer resection and
end-to-end, although there is little convincing data from com-
parisons of one type of repair with another. This decision is
based primarily on the belief that the coarctation segment con-
taining abnormal ductal tissue should be resected to prevent
recurrence.14 It is true that ductal tissue is partially excised,
and residual ductal tissue is left behind in the SFA technique.
However, Merril and colleagues10 demonstrated that the
recoarctation rate was better for SFA than that for end-to-end
in patients who were followed up for at least 5 years. It was
also pointed out by Gaynor and associates3 that increased ten-
sion at the anastomosis caused by end-to-end might result in a
high possibility of anastomotic stenosis. They used a homo-
graft patch augmentation technique for arch reconstruction in
21 of 25 patients who underwent single-stage repair.
Deep hypothermic circulatory arrest is commonly used
during not only aortic arch repair through a median ster-
TABLE 3. Survival and recoarctation between published studies after 1990 separated by single-stage versus 2-stage
approach
Year of No. of No. of Operative Long-term Freedom from
Approach Authors study patients PAB mortality actuarial survival recoarctation
Single-stage
Quaegebeur and colleagues1 1994 20 – * 80.0% at 2 y *
Brouwer and colleagues7 1996 16 – 18.8% 81.2% at 5 y 60.0% at 5 y
Ishino and colleagues2 2000 11 – 0.0% 91.0% at 1 y 100.0% at 1 y
Haas and colleagues11† 2000 21 – 14.3% 76.0% at 1 y 83.0% at 1-5 y
Gaynor and colleagues3 2000 25 – 4.0% 96.0% at 3 y 75.0% at 2 y
Two-stage
Quaegebeur and colleagues1 1994 96 – * 89.6% at 2 y *
33 33 * 90.9% at 2 y *
Merril and colleagues10 1994 44 24 2.3% 90.9% at 5 y 72.1% at 5 y
Conte and colleagues8 1995 97 48 2.0% 94.0% at 10 y 87.0% at 10 y
Brouwer and colleagues7 1996 64 10 4.7% 92.2% at 5 y 91.3% at 5 y
Seirafi and colleagues9 1998 27 8 7.4% 92.0% at 10 y 83.0% at 10 y
Ishino and colleagues2 2000 13 4 0.0% 92.3% at 3 y 91.7% at 3 y
Jahangiri and colleagues12 2000 66 17 3.2% 96.0% at 10 y 92.0% at 10 y
Present study 2001 79 79 2.5% 92.3% at 10 y 90.4% at 10 y
*Operative mortality and freedom from recoarctation were not clearly described in this multi-institutional study.
†A study in low-birth-weight infants.
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notomy but also during arterial switch operations in
neonates in many centers. It is a widespread concept that
brain damage caused by systemic hypoxia-hypotension is at
least reduced by induction of hypothermia. However, there
is evidence that neurologic injury could occur, which might
lead to transient cerebral dysfunction15,16 and delayed psy-
chomotor development.17 Only exceptional surgeons2,11,18
advocated the use of an isolated cerebral perfusion from the
right brachiocephalic artery during arch repair. However,
there is not definite proof that brain circulation is normally
maintained because the circle of Willis is hypoplastic or
incomplete in more than 70% of human subjects.19,20
Allogeneic blood transfusion is indispensable for single-
stage repair under cardiopulmonary bypass, especially in
neonates, although the possible risk of transfusion-transmit-
ted diseases have been of particular concern in cardiac
surgery. When choosing a 2-stage repair, it is possible to com-
plete procedures without blood transfusion through stages. In
fact, 8 patients underwent 2-stage repair without allogeneic
blood transfusion since 1995 of a total of 13 patients who
reached the second stage.
Disadvantages in our 2-stage repair are as follows: (1) such
a strategy requires that all infants undergo a second operation
for VSD closure and pulmonary artery debanding and (2) the
left subclavian artery must be sacrificed. We believe that the
staged strategy is justified by a good survival rate and higher
freedom from low incidence of recoarctation after 2-stage
repair compared with that after single-stage repair. We also
believe that vascular insufficiency of the left arm is quite
unusual because we have no experience of a need for amputa-
tion or a need for medical-surgical treatment after SFA. We
think the relative benefits for patients with coarctation and
VSD, at present, is clear when weighing disadvantages in both
2-stage repair and single-stage repair.
In conclusion, to minimize mortality and recoarctation
rate and also to decrease the possibility of complications
related to circulatory arrest and allogeneic blood transfu-
sion, so-called traditional 2-stage repair, to date, is still an
effective technique for coarctation associated with VSD. It
will not be until there are better results regarding, at a min-
imum, survival rate and freedom from recoarctation that sin-
gle-stage repair will be conceived to be the choice of treat-
ment. We believe that SFA and concomitant PAB performed
properly as a first-stage repair are important for better long-
term results in patients with coarctation with VSD.
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